| Literature DB >> 35919818 |
Chyou-Wei Wei1, Tsai-Kun Wu2,3, Shu-Cing Wu1, Yi-Lin Chen4,5, Ying-Ru Pan6, Yi-Chung Chien7,8,9,10, Jia-Yan Wu7,8,9,10, Yung-Lung Yu7,8,9,10,11, Giou-Teng Yiang12,13.
Abstract
Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, can induce oxidative stress and cause renal disease progression. However, the different cytotoxic effects on renal cells between IS and PCS are not stated. Due to uremic toxins are generally found in CKD patients, the mechanisms of uremic toxins-induced renal injury are required to study. Curcumin has anti-oxidant, anti-inflammatory and anti-apoptotic effects which may be potential used to protect against renal damage. In contrast, curcumin also exert cytotoxic effects on various cells. In addition, curcumin may reduce or enhance cytotoxicity combined with different chemicals treatments. However, whether curcumin may influence uremic toxins-induced renal injury is unclear. The goal of this study is to compare the different cytotoxic effects on renal cells between IS and PCS treatment, as well as the synergistic or antagonistic effects by combination treatments with curcumin and PCS. Our experimental result shows the PCS exerts a stronger antiproliferative effect on renal tubular cells than IS treatment. In addition, our study firstly demonstrates that curcumin enhances PCS-induced cell cytotoxicity through caspase-dependent apoptotic pathway and cell cycle alteration. © The author(s).Entities:
Keywords: Curcumin; Indoxyl sulfate; p-cresyl sulfate
Mesh:
Substances:
Year: 2022 PMID: 35919818 PMCID: PMC9339410 DOI: 10.7150/ijms.72646
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.642
Figure 1Cell survival rate of NRK-52E cells by PCS and IS treatments. (A) Cells were treated with 100 µM PCS or 100 µM IS. (B) Cells were treated with 200 µM PCS or 200 µM IS (C) Cells were treated with 500 µM PCS or 500 µM IS. Cell survival rates were determined at 24-96 hours by MTT assay and calculated as A570 experimental group/A570 control group × 100%. The data were calculated from four independent experiments and presented as mean ± SD. *P < 0.05.
Figure 2Cell survival rate of HK-2 cells by PCS and curcumin treatments. (A) Cells were treated with 100, 200, and 500 µM PCS. (B) Cells were treated with 8 µM curcumin. Cell survival rates were determined at 24-96 hours by MTT assay and calculated as A570 experimental group/A570 control group × 100%. The data were calculated from four independent experiments and presented as mean ± SD. *P < 0.05.
Figure 3Cell survival rate of HK-2 cells by PCS, curcumin, and PCS plus curcumin treatments. (A) Cells were treated with 100µM PCS, 8 µM curcumin and 100µM PCS plus 8 µM curcumin. (B) Cells were treated with 200 µM PCS, 8 µM curcumin and 200 µM PCS plus 8 µM curcumin. (C) Cells were treated with 500 µM PCS, 8 µM curcumin and 500 µM PCS plus 8 µM curcumin. Cell survival rates were determined at 24-96 hours by MTT assay and calculated as A570 experimental group/A570 control group × 100%. The data were calculated from four independent experiments and presented as mean ± SD. *P < 0.05.
Figure 4The percentage of G0/G1, S, and G2/M phase was indicated on HK-2 cells. (A) Control cells. (B) Cells were treated with 100µM PCS. (C) Cells were treated with 200 µM PCS. (D) Cells were treated with 8 µM curcumin. (E) Cells were treated with 100 µM PCS plus 8 µM curcumin. (F) Cells were treated with 200 µM PCS plus 8 µM curcumin.100 µM PCS. The cell cycle was analyzed by using flow cytometry at 48 hour.
| Control | PCS 100 µM | PCS 200 µM | Curcumin 8 µM | PCS100+CUR8 | PCS200+CUR8 | ||
|---|---|---|---|---|---|---|---|
| 48 Hr | Sub-G | 1.8% | 5.2% | 8% | 7.7% | 8.3% | 9.1% |
| G0/G1 | 54.9% | 39.9% | 38.7% | 49.7% | 33.7% | 33.8% | |
| S | 18.7% | 21.1% | 23.2% | 19.5% | 23.6% | 25.2% | |
| G2M | 17.0% | 20.1% | 16.4% | 18.1% | 20.0% | 19.3% |
The percentage of cell cycle phase was summarized at 48 hour on control cells, 100 µM PCS-treated cells, 200 µM PCS-treated cells, 8 µM curcumin-treated cells, 100 µM PCS plus 8 µM curcumin-treated cells and 200 µM PCS plus 8 µM curcumin-treated cells. The data was collected from Figures 4 and 5.
Figure 5The percentage of sub-G1 phase was indicated on HK-2 cells. (A) Control cells. (B) Cells were treated with 100 µM PCS. (C) Cells were treated with 200µM PCS. (D) Cells were treated with 8 µM curcumin. (E) Cells were treated with 100µM PCS plus 8 µM curcumin. (F) Cells were treated with 200 µM PCS plus 8 µM curcumin.100 µM PCS. The cell cycle was analyzed by using flow cytometry at 48 hour.
Figure 6The levels of caspase-3 and cleaved PARP. (A) Caspase-3, cleaved caspase-3 and cleaved PARP were assayed by western blot. (B) Cleaved PARP/tubulin intensity ratio was calculated. (C) Cleaved caspase-3/caspase-3 intensity ratio was calculated. The proteins were determined after 48 hours treatments on control group (lane 1 and bar1), 100 µM PCS-treated group (lane 2 and bar 2), 100 µM PCS-treated group (lane 3 and bar 3), 200 µM PCS-treated group (lane3 and bar3), 8 µM curcumin-treated group (lane4 and bar 4), 100 µM PCS plus 8 µM curcumin-treated group (lane 5 and bar 5), 200 µM PCS plus 8 µM curcumin-treated group (lane6 and bar6). The data were determined from three independent experiments and presented as mean ± SD. *P < 0.05.
Figure 7Schematic illustration depicting the roles of curcumin enhances p-cresyl sulfate-induced cytotoxic effects on renal tubular cells.